Michael Burns

Disodium (R,R)-5-[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate (CL 316,243). A potent .beta.-adrenergic agonist virtually specific for .beta.3 receptors. A promising antidiabetic and antiobesity agent

Jonathan D. Bloom, Minu Dutia, Bernard D. Johnson et al. · Journal of Medicinal Chemistry · 1992 · 295 citations · Full text

Altmetric Attention Score, Pharmacotherapy, Experimental Pharmacology +18

Effects of vanadium on glucose metabolism

E.L. Tolman, Edna Barris, Michael Burns et al. · Life Sciences · 1979 · 236 citations

Metabolic Syndrome, Energy Metabolism, Glucose Metabolism +8

Methylenetetrahydrofolate Reductase 677C→T Variant Modulates Folate Status Response to Controlled Folate Intakes in Young Women

Cheryl L. Guinotte, Michael Burns, Marie A. Caudill et al. · Journal of Nutrition · 2003 · 87 citations · Full text

Vitamin Nutrition, Nutrition, Methylenetetrahydrofolate Reductase 677C→t +13

Beta-3 adrenoceptor selectivity of the dioxolane dicarboxylate phenethanolamines.

Jo Alene Dolan, Helen A. Muenkel, Michael Burns et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 81 citations

Indanylacetic Acid Derivatives Carrying 4-Thiazolyl-phenoxy Tail Groups, a New Class of Potent PPAR α/γ/δ Pan Agonists:  Synthesis, Structure−Activity Relationship, and In Vivo Efficacy

Joachim Rudolph, Libing Chen, Dyuti Majumdar et al. · Journal of Medicinal Chemistry · 2007 · 53 citations · Full text